We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Encompass Health Opens Rehabilitation Hospital in Florida
Read MoreHide Full Article
Key Takeaways
EHC opened a 50-bed inpatient rehab hospital in Daytona Beach, its 169th nationwide and 23rd in Florida.
The hospital offers specialized therapies for stroke, brain injury, amputation and orthopedic recovery.
Daytona Beach's growing, aging population drives demand as EHC expands care under its 2025 growth plan.
Encompass Health Corporation (EHC - Free Report) announced the opening of its latest inpatient rehabilitation hospital in Daytona Beach, FL, situated at 1952 N. Williamson Blvd. This new 50-bed facility highlights the company’s ongoing commitment to expanding access to top-notch rehab care throughout the state. This hospital marks EHC's 169th hospital nationwide and the 23rd in Florida.
Encompass Health Rehabilitation Hospital provides specialized rehabilitation services tailored for patients who are recovering from strokes, brain injuries, amputations and intricate orthopedic challenges. It features private patient rooms, a therapy courtyard, an in-house dialysis suite, an activities of daily living suite, and dedicated areas for physical, occupational and speech therapies to restore functional ability and quality of life.
This new hospital represents a significant shift toward more decentralized, patient-centered care in post-acute medicine. It is anticipated to greatly enhance recovery outcomes while also lightening the load on general hospitals in the area. As Daytona Beach is a rapidly growing area with an aging population, it reflects a strong demand for inpatient rehabilitation services. By establishing a facility here, EHC not only addresses the local needs but also enhances its network throughout Florida.
The Daytona Beach hospital is part of Encompass Health’s broader 2025 growth plan. The company plans to open seven de novo hospitals this year, including a 50-bed satellite facility, while also adding 100-120 beds to existing hospitals, further strengthening its national footprint.
In June 2025, EHC announced its initial plans to construct a freestanding inpatient rehabilitation hospital in North Las Vegas, NV. Equipped with 50 beds, the facility is expected to commence operations by 2028.
EHC’s Price Performance
Year to date, EHC shares have gained 16.2% against the industry’s decline of 1.5%.
The Zacks Consensus Estimate for Envista’s current-year earnings of $1.04 per share has witnessed two upward revisions in the past 60 days against no movement in the opposite direction. Envista beat earnings estimates in three of the trailing four quarters and missed once. The consensus estimate for current-year revenues is pegged at $2.6 billion, suggesting 1.7% year-over-year growth.
The Zacks Consensus Estimate for Fresenius Medical Care’s current-year earnings of $2.21 per share has witnessed four upward revisions in the past 60 days against no movement in the opposite direction. Fresenius Medical Care beat earnings estimates in three of the trailing four quarters and met once, with the average surprise being 6.6%. The consensus estimate for current-year revenues is pegged at $21.9 billion, suggesting 4.8% year-over-year growth.
The Zacks Consensus Estimate for Phibro Animal Health’s current-year earnings of $2.04 per share has witnessed one upward revision in the past 60 days against no movement in the opposite direction. Phibro Animal Health beat earnings estimates in each of the trailing four quarters, with an average surprise being 30.6%. The consensus estimate for current-year revenues is pegged at $1.3 billion, suggesting 25.7% year-over-year growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Encompass Health Opens Rehabilitation Hospital in Florida
Key Takeaways
Encompass Health Corporation (EHC - Free Report) announced the opening of its latest inpatient rehabilitation hospital in Daytona Beach, FL, situated at 1952 N. Williamson Blvd. This new 50-bed facility highlights the company’s ongoing commitment to expanding access to top-notch rehab care throughout the state. This hospital marks EHC's 169th hospital nationwide and the 23rd in Florida.
Encompass Health Rehabilitation Hospital provides specialized rehabilitation services tailored for patients who are recovering from strokes, brain injuries, amputations and intricate orthopedic challenges. It features private patient rooms, a therapy courtyard, an in-house dialysis suite, an activities of daily living suite, and dedicated areas for physical, occupational and speech therapies to restore functional ability and quality of life.
This new hospital represents a significant shift toward more decentralized, patient-centered care in post-acute medicine. It is anticipated to greatly enhance recovery outcomes while also lightening the load on general hospitals in the area. As Daytona Beach is a rapidly growing area with an aging population, it reflects a strong demand for inpatient rehabilitation services. By establishing a facility here, EHC not only addresses the local needs but also enhances its network throughout Florida.
The Daytona Beach hospital is part of Encompass Health’s broader 2025 growth plan. The company plans to open seven de novo hospitals this year, including a 50-bed satellite facility, while also adding 100-120 beds to existing hospitals, further strengthening its national footprint.
In June 2025, EHC announced its initial plans to construct a freestanding inpatient rehabilitation hospital in North Las Vegas, NV. Equipped with 50 beds, the facility is expected to commence operations by 2028.
EHC’s Price Performance
Year to date, EHC shares have gained 16.2% against the industry’s decline of 1.5%.
Image Source: Zacks Investment Research
EHC’s Zacks Rank & Key Picks
EHC currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Medical space are Envista Holdings Corp (NVST - Free Report) , Fresenius Medical Care AG & Co. (FMS - Free Report) and Phibro Animal Health Corp (PAHC - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Envista’s current-year earnings of $1.04 per share has witnessed two upward revisions in the past 60 days against no movement in the opposite direction. Envista beat earnings estimates in three of the trailing four quarters and missed once. The consensus estimate for current-year revenues is pegged at $2.6 billion, suggesting 1.7% year-over-year growth.
The Zacks Consensus Estimate for Fresenius Medical Care’s current-year earnings of $2.21 per share has witnessed four upward revisions in the past 60 days against no movement in the opposite direction. Fresenius Medical Care beat earnings estimates in three of the trailing four quarters and met once, with the average surprise being 6.6%. The consensus estimate for current-year revenues is pegged at $21.9 billion, suggesting 4.8% year-over-year growth.
The Zacks Consensus Estimate for Phibro Animal Health’s current-year earnings of $2.04 per share has witnessed one upward revision in the past 60 days against no movement in the opposite direction. Phibro Animal Health beat earnings estimates in each of the trailing four quarters, with an average surprise being 30.6%. The consensus estimate for current-year revenues is pegged at $1.3 billion, suggesting 25.7% year-over-year growth.